Ausgabe 3/2018
Inhalt (10 Artikel)
Frailty in Hematologic Malignancy
Thuy T. Koll, Ashley E. Rosko
The Effect of Psychosocial Interventions on Outcomes for Caregivers of Hematopoietic Cell Transplant Patients
Lauren R. Bangerter, Joan M. Griffin, Shelby Langer, Bashar Hasan, Wonsun (Sunny) Kim, M. Hassan Murad, Nandita Khera
Management of Myelofibrosis-Related Cytopenias
Prithviraj Bose, Srdan Verstovsek
Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis
Francesco Passamonti, Barbara Mora, Daniela Barraco, Margherita Maffioli
Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms
Imo J. Akpan, Brady Lee Stein
Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes
Melanie C. Dispenza, Bruce S. Bochner
Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making
James A. Kennedy, Gabriela Hobbs
Novel Approaches for the Management of AL Amyloidosis
Nisha S. Joseph, Jonathan L. Kaufman
Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney—What We Know and What the Future May Hold
Sandhya Manohar, Samih H. Nasr, Nelson Leung
How We Manage Patients with Plasmacytomas
Despina Fotiou, Meletios A. Dimopoulos, Efstathios Kastritis